Release of November 2025 licensure exam results

The Pharmacy and Medicines Regulatory Authority (PMRA) is pleased to announce release of results of registration examinations for pharmacists, pharmacy technologists and pharmacy assistants which were administered on 27^th and 28^th November 2025.

Candidates who sat for the examinations can access their results through the Pharmacy Personnel Licensing Portal (https://pmis.pmra.mw/login).

For those candidates who sat for the examinations to enroll for internship program should confirm their results with Mr. Clement Ngwira on +265 881 79 09 93  or +265 999 379 544 starting Wednesday, 31^st December 2025 from 07:30 a.m.

PMRA is further reminding all registered pharmacy personnel that Section 26 (2) of the PMRA Act No. 9 of 2019 provides that a person registered under section 25 of the Act shall not be allowed to practice without a practicing licence issued at a fee by the Authority.

This implies that to practice pharmacy in Malawi, both new and old registrants are supposed to apply for a practicing licence. Those with existing accounts on the pharmacy personnel licensing portal can apply for their practicing license directly through the portal..

For further enquiries, please contact PMRA on +265 881 79 09 93 / +265 999 379 544 or email at info@pmra.mw during normal working hours.

Meet PMRA’s new Board of Directors

Government appointed new Board of Directors for the Pharmacy and Medicines Regulatory Authority (PMRA) effective 4th December, 2025. The appointment was in accordance with Section 6(1) of the PMRA Act No. 9 of 2019.

The composition of the new Board is as follows:

1. Ms. Charlotte Misoya – Chairperson
2. Prof. Adamson Muula – Member
3. Ms. Cecilia Tembo – Member
4. Mr. Patrick Gwedeza – Member
5. Dr. Wachimota Phiri – Member
6. Mr. Keith Lipato – Member
7. Mr. Elos Lodzeni – Member
8. Mrs. Ruth Kasalika – Member
   

The ex-officio members of the Board are as follows:

1. Secretary for Health and Sanitation;
2. Solicitor General; and
3. Controller of Statutory Corporations

Malawi registers Lenacapavir for HIV-1 prevention

The Pharmacy and Medicines Regulatory Authority (PMRA) and the National AIDS Commission (NAC) are pleased to announce the registration of Lenacapavir, an innovative, long-acting medicine that is used for the prevention of HIV-1 infection.

Read full statement in the link below: